Definitions
from Wiktionary, Creative Commons Attribution/Share-Alike License.
- noun medicine A
variant of abiopharmaceutical that is marketed following the expiry of the original patent
Etymologies
Sorry, no etymologies found.
Support
Help support Wordnik (and make this page ad-free) by adopting the word biosimilar.
Examples
-
By partnering with Hanwha, U.S.-based Merck could boost its profit by selling so-called biosimilar drugs, which attempt to copy the production process for drugs that are no longer protected by a patent.
Merck Buys Hanwha Drug-Marketing Rights Min-Jeong Lee 2011
-
By partnering with Hanwha, U.S.-based Merck could boost its profit by selling so-called biosimilar drugs, which attempt to copy the production process for drugs that are no longer protected by a patent.
Merck Buys Hanwha Drug-Marketing Rights Min-Jeong Lee 2011
-
Tuesday said they formed a joint venture to tap the growing potential of so-called biosimilar medicines.
-
The Swiss drugmaker's generics unit Sandoz started mid-stage trials in rheumatoid arthritis patients for the so-called biosimilar version of the drug, Sandoz said on Monday.
FOXNews.com 2011
-
International Corp to develop copies of biotech medicines, deepening the U.S. drugmaker's investment in so-called biosimilar medicines.
Reuters: Top News 2011
-
The Swiss drugmaker's generics unit Sandoz started mid-stage trials in rheumatoid arthritis patients for the so-called biosimilar version of the drug, Sandoz said on Monday.
Reuters: Top News 2011
-
As you may know, a biosimilar is a generic biologic.
GuruFocus Updates - 2010
-
Parexel International Corp. will provide clinical development services for so-called "biosimilar" candidates to Merck's BioVentures unit.
Merck Teams Up With Parexel on Biosimilars Peter Loftus 2011
-
That's one of the thorny questions addressed by the FDA this week in a two-day, open-to-the-public meeting about "biosimilar" drugs -- second-generation versions of drugs made from living organisms, or "biologics."
John Horton: Biologics: Are Unsafe Drugs an 'Acceptable Risk?' FDA Should Say 'No!' John Horton 2010
-
But depending on how similar it is, a "biosimilar" may or may not be equally as safe and effective as the original biologic.
John Horton: Biologics: Are Unsafe Drugs an 'Acceptable Risk?' FDA Should Say 'No!' John Horton 2010
-
It created a pathway for federal approval of biosimilars, which are near-copies of biologic drugs, made from living cells.
If the Supreme Court Ends Obamacare, Here’s What It Would Mean By 2021
Comments
Log in or sign up to get involved in the conversation. It's quick and easy.